These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
552 related items for PubMed ID: 26106828
1. Diagnostic and therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: the Italian experience. Cancian M, Italian network for C1-INH-HAE (ITACA). Curr Opin Allergy Clin Immunol; 2015 Aug; 15(4):383-91. PubMed ID: 26106828 [Abstract] [Full Text] [Related]
2. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE). Sabharwal G, Craig T. Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442 [Abstract] [Full Text] [Related]
6. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy. Hakl R, Kuklínek P, Krčmová I, Králíčková P, Freiberger T, Janků P, Vlková M, Litzman J. J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305 [Abstract] [Full Text] [Related]
7. Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema. Valerieva A, Caccia S, Cicardi M. Expert Rev Clin Immunol; 2018 Sep; 14(9):707-718. PubMed ID: 30021471 [Abstract] [Full Text] [Related]
8. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency. Zanichelli A, Wu MA, Andreoli A, Mansi M, Cicardi M. Expert Opin Drug Saf; 2015 Sep; 14(11):1725-36. PubMed ID: 26429506 [Abstract] [Full Text] [Related]
11. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema. Riedl M. Clin Drug Investig; 2015 Jul; 35(7):407-17. PubMed ID: 26091744 [Abstract] [Full Text] [Related]
12. An evidence based therapeutic approach to hereditary and acquired angioedema. Bork K. Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294 [Abstract] [Full Text] [Related]
14. Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study. Triggianese P, Guarino MD, Pellicano C, Borzi M, Greco E, Modica S, De Carolis C, Perricone R. Int Arch Allergy Immunol; 2017 Aug; 172(1):55-63. PubMed ID: 28222436 [Abstract] [Full Text] [Related]
15. Modeling Cost-Effectiveness of On-Demand Treatment for Hereditary Angioedema Attacks. Bernstein JA, Tyson C, Relan A, Adams P, Magar R. J Manag Care Spec Pharm; 2020 Feb; 26(2):203-210. PubMed ID: 31841366 [Abstract] [Full Text] [Related]
19. Current and emerging management options for hereditary angioedema in the US. Epstein TG, Bernstein JA. Drugs; 2008 Oct 01; 68(18):2561-73. PubMed ID: 19093699 [Abstract] [Full Text] [Related]
20. Current management options for hereditary angioedema. Bork K. Curr Allergy Asthma Rep; 2012 Aug 01; 12(4):273-80. PubMed ID: 22729959 [Abstract] [Full Text] [Related] Page: [Next] [New Search]